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Authors present the case of 66-year-old patient after repeated systemic embolisations (lower
extremity, axillary artery), admitted for inferior myocardial infarction. Coronary angiogra-
phy demonstrated peripheral subtotal occlusion of posterior descending artery (PDA) of
embolic origin. Transoesophageal echocardiography (TOE) revealed mobile mass on aortic
valve, which was subsequently extirpated surgically. Histological examination described
thrombus. Case report depicts the native aortic valve thrombus as a rare source of systemic
or coronary embolisation. It simultaneously supports the indication of TOE at systemic
embolisations of unknown source, even if transthoracic echocardiography (TTE) ﬁnding is
normal, and shows its key role in diagnostic algorithm in similar events.
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.Introduction
Embolisation as a mechanism of myocardial infarction is well
known [1,2]. Prizel et al. found autopsy evidence of infarction
caused by emboli in 5% hearts, selected for post mortem
coronary angiogram because of known or suspected history of
cardiovascular or pulmonary disease (that was 13% of all
autopsy-conﬁrmed infarctions) [1]. Its sources can be endo-
carditis (infective, nonbacterial thrombotic), thrombi from left-
sided heart cavities, valves (native, prosthetic), paradoxical
embolism, tumors (myxoma, ﬁbroelastoma), or heart cathe-
terization or surgery [3]. Nevertheless the native aortic valve* Correspondence to: Kardiologie, Městská nemocnice Ostrava, Nem
fax: +420 596 192 343.
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0010-8650/# 2013 The Czech Society of Cardiology. Published by Elsethrombosis as a source of embolisation into the coronary
artery is uncommon.
Case report
Sixty six-year-old male with repeated systemic embolisation
in his medical history, treated in other hospital: 2 years before
current admission the acute occlusion of left low leg arteries,
treated with partially successful local thrombolysis, and
embolic occlusion of right axillary artery before 13 months,
resolved by embolectomy. Subsequent hematologic examina-
tion for possible hypercoagulable state revealed just mildocniční 20, 728 80 Ostrava, Czech Republic. Tel.: +420 596 194 279;
vier Urban & Partner Sp. z o.o. All rights reserved..
Fig. 2 – Left coronary artery.
Fig. 3 – Transoesophageal finding of mass attached to the
aortic valve.
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warfarin. There were still hypertension, celiac disease and
mild chronic sideropenic anemia, related to celiakia, in his
medical history. No thrombembolic event occurred in family
history. Chronic medication included hydrochlorothiazide and
amiloride in ﬁxed-dose combination, oral iron supplement,
allopurinol, betahistine. Warfarin was withdrawn 5 months
before admission.
Patient was presented to our center from the emergency
department of community hospital with repeated chest pain,
the latest 2 days before admission, and new Q waves in leads II,
III, aVF in his electrocardiogram. On admission the patient's
state was stable, he was without dyspnea, his blood pressure
was 120/80, heart rate 84 min1 and his lungs were clear within
the auscultation, abdomen and lower extremities without
abnormalities. The patient was referred for cardiac catheteri-
zation, coronary angiography demonstrated peripheral subto-
tal obstruction of PDA of embolic origin, only slight signs of
atherosclerosis (Figs. 1 and 2). With regard to peripheral
localization of thrombembolus, ECG signs of deﬁnite Q-
infarction, clinical stabilization and absence of symptoms,
the approach was conservative.
Laboratory tests showed microcytic, sideropenic anemia
(hemoglobin 109. . .94 g/l), troponin I 25.401 ng/ml, iron level
3.4 mmol/l, renal insufﬁciency (kreatinin 162. . .149 mmol/l),
total cholesterol 5.15 mmol/l, triacylglycerides 1.78 mmol/l,
LDL-cholesterol 3.22 mmol/l, HDL-cholesterol 0.91 mmol/l.
Transthoracic echocardiography reveals left ventricle ejection
fraction 45%, inferior wall hypokinesis, mild aortic and
tricuspidal insufﬁciency (trace regurgitation), mitral regurgi-
tation I/IV. Chest X-ray was normal. Within search for a source
of embolisation TOE was performed and showed echogenic
mobile ovale mass (Fig. 3) attached by a stalk to the right
coronary leaﬂet of aortic valve, 2710 mm, with trace
regurgitation. There was mitral regurgitation II/IV, left atrium
including the appendage without clots. Our differential
diagnosis of the mass included ﬁbroelastoma, other type of
tumor or thrombus. Vegetation was considered unlikely.
Additional examinations performed within the hospitali-
zation: abdominal ultrasonography revealed a ‘‘bright’’ liverFig. 1 – Right coronary artery with peripheral subtotal
obstruction in PDA (arrows).with increased echogenicity, chronic nephropathy on the left,
ﬁbrogastroscopy described sliding hiatus hernia, suspected
gastroespohageal reﬂux and atrophic mucosa in duodenum
(‘‘mosaic’’ pattern), suspected of celiakia.
The course of hospitalization, lasting 5 days, was uncom-
plicated, no further systemic embolisation occurred. Antic-
oagulation with low-molecular weight heparin was initiated,
followed by warfarin in usual way.
4 weeks later patient underwent surgery: in cardiopulmo-
nary bypass the mass of aortic valve was extirpated,
macroscopically described as fragile, crumbly, jelly-like. Based
on perioperative TOE, mitral valve anuloplasty was performed
simultaneously. Histological ﬁnding depicts mixed, organized,
mainly red thrombus (Fig. 4). Postoperative course was
uneventful, patient was discharged on 10th day with warfarin,
intended for lifelong. Currently (9 months after surgery)
patient is doing well, managed by cardiologist and angiologist
in outpatient clinics.
Discussion
The native aortic valve thrombus as a cause of peripheral
embolisation, or more precisely myocardial infarction, is rare
Fig. 4 – Histological finding: particle formed of structures of
mixed, predominantly red thrombus pervaded with
dispersed, in some places merging granulocytotic
cellulisation. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of
this article.)
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genic state (antiphospholipid syndrome, protein S deﬁciency)
[7] or with systemic connective tissue disease (systemic lupus
erythematosus), alternatively formed on diseased valve
(calciﬁcations, amyloidosis) [8,9] or as a consequence of
trauma (surgery, cathetrization) [10].
In our case the exact mechanism responsible for thrombus
formation was not clearly identiﬁed. Hematological examina-
tion revealed just mild hypercoagulative state (mild hyperho-
mocysteinemia, heterozygous for the methylentetrahydrofolate
reductase gene mutation), only trace regurgitation on the aortic
valve was discovered as an organic change. Celiac disease is
known as a potential risk factor for venous thrombosis [11,12],
however only a few cases reported patients with thrombosis in
arterial bed, and none of them refers the intracardial or valvular
thrombus as a source of embolisation [13,14]. There could be a
theoretical link of celiac disease as an autoimmune disorder to
the non-bacterial thrombotic endocarditis, but that was not
proved in the presented case.
Search for a potential cardiac source of systemic embolism
represents one of principal indications for transoesophageal
echocardiography, that plays then key role in diagnostic
algorithm of embolic events, even with normal ﬁnding in
transthoracic examination [15–17]. The same was true in our
case of patient after repeated systemic embolisation (arteries
of lower extremity, axillary artery, right coronary artery),
where transoesophageal echocardiography revealed the mass
on aortic valve, undiscovered in transthoracic way. The
histological ﬁnding after surgical resection conﬁrmed char-
acteristics of a thrombus.Conclusion
Spontaneous native aortic valve thrombosis is infrequent. It
should be taken into the consideration in the differential
diagnosis of valve-associated masses and causes of systemic
embolism. Transoesophageal echocardiography is of crucial
importance in its detection.
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